The sulforaphane thats derived from glucosinolates activates apoptosis, reduces cancer-cell proliferation, and stimulates detoxification pathways that help eliminate carcinogenic compounds from the body
In mild to moderate disease : 300 mg to 600 mg daily by slow intramuscular or intravenous injection
Chronic structural damage presents different challenges
Patients should be educated to recognise and report warning signs promptly, including: Seizure warning signs : unusual sensations, confusion, loss of consciousness, or convulsive movements Cardiovascular symptoms : chest pain, palpitations, severe dizziness, or shortness of breath Psychiatric changes : worsening depression, anxiety, agitation, panic attacks, or thoughts of self-harm Severe gastrointestinal symptoms : persistent vomiting, severe abdominal pain (which may indicate pancreatitis), or signs of dehydration Hypoglycaemia symptoms (if diabetic): tremor, sweating, confusion, or rapid heartbeat Medication adherence and technique should be reviewed regularly